Astrazeneca (AZN) Change in Intangibles (2009 - 2026)

Astrazeneca (AZN) has reported Change in Intangibles for 17 consecutive years, with -$991.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Intangibles fell 83.52% year-over-year to -$991.0 million; the TTM figure through Mar 2026 stood at -$3.5 billion (down 76.07% YoY), while the FY2025 annual figure was -$3.1 billion, down 16.27% from the prior year.
• Change in Intangibles came in at -$991.0 million for Q1 2026 at Astrazeneca, down from -$251.0 million in the prior quarter.
• The five-year high for Change in Intangibles was -$144.0 million in Q1 2022, with the low at -$1.3 billion in Q2 2025.
• Average Change in Intangibles over 5 years is -$662.9 million, with a median of -$540.0 million recorded in 2025.
• Across the five-year window, Change in Intangibles plunged 749.31% in 2023 and surged 54.55% in 2025, its largest moves.
• Year by year, Change in Intangibles stood at -$290.0 million in 2022, then increased by 26.55% to -$213.0 million in 2023, then retreated by 15.96% to -$247.0 million in 2024, then dropped by 1.62% to -$251.0 million in 2025, then plunged by 294.82% to -$991.0 million in 2026.
• According to Business Quant data, Change in Intangibles over the past three periods registered -$991.0 million, -$251.0 million, and -$1.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.